about
Disruptive chemicals, senescence and immortalityAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadPharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodentsIs aspirin treatment an appropriate intervention to osteoporosis?In search of antiaging modalities: evaluation of mTOR- and ROS/DNA damage-signaling by cytometry.NOX2-Induced Activation of Arginase and Diabetes-Induced Retinal Endothelial Cell Senescence.Effects of aging on angiogenesis.The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseasePotential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signalingMechanisms of dysfunction in senescent pulmonary endothelium.How to control NO production in cells: N(omega),N(omega)-dimethyl-L-arginine dimethylaminohydrolase as a novel drug target.Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients.Telomeres and atherosclerosisFree radicals and senescence.Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis.The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling.Positive influence of aspirin on coronary endothelial function: Importance of the dose.New and old mechanisms associated with hypertension in the elderly.The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells.ProtChemSI: a network of protein-chemical structural interactionsAspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans.Vascular Aging: Implications for Cardiovascular Disease and Therapy.Low concentrations of salicylic acid delay methyl jasmonate-induced leaf senescence by up-regulating nitric oxide synthase activity.Telomeres, Aging and Exercise: Guilty by Association?
P2860
Q27026235-A8421756-CC37-482F-9D38-E9C8B9275556Q28397132-93260A40-D453-4156-89B9-131C3C426F54Q28473076-7C4C2BB5-CB2C-41C6-B10B-BB8BE524DB03Q33813510-99DD895F-A37D-4901-A23D-8C8144622574Q33841800-BD4451AF-1B61-4CCC-B7B5-26B995853379Q33845094-F269E5ED-C52E-4F5B-8AD6-4A607F60559FQ33914406-4635C3BB-BAF6-40F7-85E7-6DAF439C22BDQ33940891-CC5EF855-9E31-4A73-A04A-0258E77B560AQ34567724-3D277778-2117-4297-A3F2-DC19F1815E01Q35815760-949E6FEC-CED9-4E84-8270-39BA27E2EACDQ36471209-33A31733-087F-419D-870C-04CA11C3405DQ36982850-DD2DFF06-B032-45EF-96EF-39161D489690Q37041786-A52C4D7F-B96D-4B02-B432-D0778D4F9CD8Q37087711-CBCAE368-0EB4-4187-9939-EE339A2FE265Q37222244-A55044B2-58FA-4D65-AAE2-AFD27497A4E2Q37331195-3A61AD0D-D34D-4785-BF35-F50523EA1088Q37378488-ADF9CB75-983C-4C48-8777-52FD665F3559Q38791329-0D414CBB-27DF-4A24-BAFD-9B957BBA3801Q39093077-2F453E4B-BBFC-4D9B-A135-F9FEDAD99175Q39972430-24D414AC-9B61-417F-853B-587A64D891B0Q41072898-2603034E-504F-4E3D-9220-437C888AC445Q41728173-079E4A2D-D6D9-4955-9DED-05EB0D2F6317Q46513459-36F41C20-C4F1-438F-BEE5-C875AAFF7418Q47811954-37D893F7-D9AD-40FC-946C-F6060D87A22E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aspirin reduces endothelial cell senescence
@ast
Aspirin reduces endothelial cell senescence
@en
Aspirin reduces endothelial cell senescence
@nl
type
label
Aspirin reduces endothelial cell senescence
@ast
Aspirin reduces endothelial cell senescence
@en
Aspirin reduces endothelial cell senescence
@nl
prefLabel
Aspirin reduces endothelial cell senescence
@ast
Aspirin reduces endothelial cell senescence
@en
Aspirin reduces endothelial cell senescence
@nl
P2093
P1476
Aspirin reduces endothelial cell senescence
@en
P2093
Fortunato Scalera
Henning Schröder
Jens Martens-Lobenhoffer
Michael Täger
Stefanie M Bode-Böger
P304
P356
10.1016/J.BBRC.2005.07.014
P407
P577
2005-09-09T00:00:00Z